Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/23
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 05/31/17
Due: 05/31/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU Patients | NCT05040776 | eXIthera Pharmaceuticals | user2@example.com | None | 2023-10-31 | 2025-05-31 | 2026-05-31 | - | - | 2025-07-14 |
| Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy Subjects | NCT02914353 | eXIthera Pharmaceuticals | user2@example.com | None | 2016-07-31 | 2017-05-31 | 2018-05-31 | - | - | 2025-07-14 |